Long-term Oncologic Outcome of MILS in Patients With CRLM and Prognostic Indicators Clinical Trial
| Verified date | July 2012 |
| Source | University Hospital, Gasthuisberg |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Belgium: Ethics Committee |
| Study type | Observational |
Only few reports exist on long-term survival after minimally invasive liver surgery (MILS for colorectal liver metastases. No data are available assessing prognostic factors in the era of current modern treatment strategies. The aim of the current study is to analyze the long-term oncologic outcome after MILS for metastases from colorectal cancer and determine prognostic indicators.
| Status | Completed |
| Enrollment | 274 |
| Est. completion date | July 2012 |
| Est. primary completion date | December 2008 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years to 90 Years |
| Eligibility |
Inclusion Criteria: - Patients with CRLM - Surgery: resection and/or ablation - preoperative chemotherapy and/or biological agents are allowed - postoperative chemotherapy and/or biological agents are allowed - simultaneous colorectal resection is allowed Exclusion Criteria: - primary liver cancer - benign liver tumors - pregnancy |
Observational Model: Cohort, Time Perspective: Prospective
| Country | Name | City | State |
|---|---|---|---|
| Belgium | University Hospitals Leuven KUL | Leuven | Vlaams-Brabant |
| Lead Sponsor | Collaborator |
|---|---|
| University Hospital, Gasthuisberg |
Belgium,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | overall survival | 5 years | No | |
| Secondary | prognostic variables | 5 year | No |